Faculty Information - OMOTO Kazuya

（Last updated : 2026-06-02 14:32:32）

OMOTO Kazuya
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Case report	Requiring caution in the interpretation of donor- derived cell- free DNA levels during cancer treatment in a kidney transplant recipient.: A case report 2026/05
2.	Original article	Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end-stage renal disease populations. 2026/03
3.	Case report	Safety management of kidneytransplantation in patients with Behçet’s disease: A case report with literature review 2026/02/10
4.	Original article	Risk assessment of cytomegalovirus reactivation after kidney transplantation under a universal preemptive strategy in the era of intravenous immunoglobulin-based desensitization therapy. 2026/02
5.	Other	Incidence and causes of surgical reintervention following living kidney transplantation: Insights from 534 consecutive cases. 2025/08
6.	Original article	Long-term outcomes of cross-match positive living kidney transplantation: A retrospective study. 2025/08
7.	Other	Performance of donor-derived cell-Free DNA testing for rejection detection in Japanese kidney transplants: Insights from a multicenter study. 2025/08
8.	Other	Relative changes in donor-derived cell-free DNA as a marker of allograft rejection in a kidney transplant recipient with metastatic cancer undergoing immunotherapy 2025/08
9.	Other	Surgical complications and risk factors in 2,095 cases of pure retroperitoneoscopic living donor nephrectomy: A 20-year experience. 2025/08
10.	Other	The coeffi cient of variation of tacrolimus QD at 1 year posttransplant is associated with mid-long term kidney graft function. 2025/08
11.	Original article	Personalized prediction model generated with machine learning for kidney function one year after living kidney donation. 2025/07/01
12.	Original article	Donor-derived cell-free DNA for diagnosing subclinical rejection: A pilot multicenter study in Japanese living-donor kidney transplantation. 2025/07
13.	Case report	Perioperative management of kidney transplantation in patients with myasthenia gravis: a case report with literature review. 2025/06/20
14.	Original article	Comparing surgical outcomes between robot-assisted laparoscopic and open partial nephrectomy for allograft kidney tumors: a retrospective, single-center study. 2025/03
15.	Original article	Outcomes of kidney transplantation in recipients with SARS-cov-2 infection: a 282-case single-center experience in Japan. 2025/02
16.	Original article	Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study. 2024/10/03
17.	Original article	Renal outcome of living kidney donors aged more than 70 years. 2024/09
18.	Original article	Comparative analysis of real-world efficacy and safety of hypoxia-inducible factor prolyl-hydroxylase inhibitors in kidney transplant recipients versus nontransplant individuals: A single-center study. 2024/07
19.	Original article	Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis. 2024/04/14
20.	Original article	Safety of docetaxel in a patient with metastatic castration-resistant prostate cancer after kidney transplantation: A case report. 2024/04
21.	Original article	The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks. 2024/04
22.	Original article	Higher donor age and severe microvascular inflammation are risk factors for chronic rejection after treatment of active antibody-mediated rejection. 2024/02
23.	Original article	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. 2023/11
24.	Case report	A case of kidney transplantation for complete C4 deficiency with recurrent IgM-monoclonal gammopathy of renal significance (MGRS) associated nephropathy. 2023/09
25.	Original article	Kidney transplantation after multiple urinary tract conversion with an ileal conduit: A case report. 2023/05/14
26.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
27.	Original article	Case report: suspected hyperacute rejection during living kidney transplantation. 2023/05/01
28.	Original article	Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan academic consortium of kidney transplantation study-II. 2023/05
29.	Original article	A Comparative Study on the Variation in Seropositivity Rates After 2-Dose COVID-19 Vaccination Before or After Transplant: A Single-Center Analysis. 2022/12
30.	Case report	Allogeneic kidney transplantation after COVID-19: A case report. 2022/07
31.	Case report	Case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. 2022/07
32.	Case report	Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. 2022/07
33.	Original article	Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A retrospective cohort study at a single transplant institute in Japan. 2022/05
34.	Original article	Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. 2022/03
35.	Original article	Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg. 2022/03
36.	Case report	Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. 2022/01
37.	Case report	Fluorescence in situ hybridization for the origin of de novo renal cell carcinoma in a kidney allograft: A case report. 2021/10
38.	Original article	Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients 2021/09/08
39.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. 2021/06
40.	Review article	The significance of HLA antibody screening test. 2020/12/10
41.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7-years of follow-up after renal transplantation. 2020/12
42.	Original article	Clinicopathologic analyses of chronic vascular rejection after kidney transplantation. 2020/07
43.	Original article	Post-donation satisfaction in kidney transplantation: a survey of living donors in Japan 2019/10/26
44.	Original article	Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study 2019/10/03
45.	Original article	Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance - an experimental study. 2019/04
46.	Original article	Monoclonal immunoglobulin G deposits on tubular basement membrane in renal allograft: is this significant for chronic allograft injury? 2019/04
47.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
48.	Original article	Clinical and Pathological Features of Plasma Cell-Rich Acute Rejection After Kidney Transplantation. 2018/05
49.	Original article	iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model. 2018/02
50.	Original article	Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation. 2017/06
51.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
52.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
53.	Case report	Successful kidney transplantation after stepwise desensitization using rituximab and bortezomib in a highly HLA-sensitized and ABO incompatible high titer patient. 2016/07
54.	Case report	Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab. 2016/07
55.	Original article	Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up. 2016/05
56.	Original article	Post-transplant lymphoproliferative disorder in kidney transplant recipients: A single-center experience in Japan. 2016/04
57.	Original article	Preemptive living donor kidney transplantation and kidney function at the initial hospital visit: A single-center casee-control study. 2016/04
58.	Original article	Robot-assisted radical prostatectomy for localized prostate cancer in asian renal transplant recipients. 2016/04
59.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
60.	Original article	Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. 2016/03
61.	Original article	Reliability of tacrolimus determination using Electro-Chemiluminesence Immunoas-say(ECLIA). 2016/03
62.	Original article	Clonal deletion established via invariant NKT cell activation and costimulatory blockade requires in vivo expansion of regulatory T cells. 2016/02
63.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
64.	Original article	Evaluation of the variability among two reference Flow Cytometry Crossmatch. 2015/10
65.	Original article	Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: A case report and review of the literature. 2015/10
66.	Case report	A Case of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation Associated With Variant Conversion in the Columbia Classification 2015/07
67.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
68.	Original article	The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients. 2015/07
69.	Original article	Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer. 2015/06
70.	Original article	Evaluation of assay methods for tacrolimus concentration on renal transplantation-CLIA, EMIT, and ECLIA- 2015/03
71.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
72.	Other	The phenotype of repopulating B cell after rituximab therapy in kidney transplant patients. 2014/11
73.	Original article	Influence of dialysis duration on the outcome of living kidney transplantation. 2014/10
74.	Original article	Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients. 2014/08
75.	Other	The authors' reply 2014/08
76.	Original article	Clinical and pathological analyses of transplant glomerulopathy cases. 2014/06
77.	Original article	A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells With Costimulatory Blockade 2014/03
78.	Original article	Influence of Dialysis Duration on the Outcome of Living Kidney Transplantation 2014/02
79.	Original article	Impact of right-sided nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy at single center 2013/10
80.	Original article	Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model 2013/10
81.	Original article	Detectability of Renal Arteries in Living Renal Donors Using Multi-Detector CT: Comparison among Axial and Three-Dimensional Reconstruction Images 2013/09
82.	Original article	Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome 2013/09
83.	Original article	Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus 2013/07
84.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
85.	Original article	Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection 2012/09
86.	Original article	Interleukin-6 Receptor Signaling Disruption Prevents Cardiac Allograft Deterioration in Mice 2012/08
87.	Original article	Acute vascular rejection after renal transplantation and isolated v-lesion 2012/07
88.	Original article	Clinical and pathological analysis of transplant glomerulopathy cases 2012/07
89.	Original article	Improvement of Urinary Dysfunction After Kidney Transplantation by Administration of the Antimuscarinic Agent-Prospective Randomized Controlled Study 2012/03
90.	Original article	Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period 2012/02
91.	Original article	Clinicopathologic Analysis of Acute Vascular Rejection Cases After Renal Transplantation 2012/02
92.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2012
93.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
94.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
95.	Original article	Kidney Transplantation at Tokyo Women's Medical University 2011
96.	Original article	Bladder function of end-stage renal disease patients 2010/09
97.	Original article	Clinicopathological analysis of acute vascular rejection cases after renal transplantation. 2010/07
98.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
99.	Original article	Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. 2010
100.	Original article	Risk factors for deterioration of renal function after donor nephrectomy 2010
101.	Original article	Clinicopathological analysis of transplant glomerulopathy cases 2009/08
102.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
103.	Original article	Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation 2009
104.	Original article	A case of plasma cell-rich acute rejection 18 months after kidney transplantation successfully treated with steroid pulse therapy 2008/07
105.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
106.	Original article	Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation 2008/06
107.	Original article	Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation 2008/01
108.	Original article	Clinical and Histological Analysis of Chronic Tacrolimus Nephrotoxicity in Renal Allografts 2008
Display 5 items
Display all(108)

■ Academic conference presentation

1.	Surgical complications and risk factors in 2,095 cases of pure retroperitoneoscopic living donor nephrectomy: a 20-year experience. （Poster notice，General） 2026/04/24
2.	Analyses of living kidney transplantation with crossmatch-positive cases （Speech，Panelist at Symposium/Workshop (Other)） 2026/04/23
3.	Donor-derived nephritis on pre-transplant biopsy does not impair post-transplant renal function in recipients or donors. （Speech，General） 2026/04/23
4.	Prognostic evaluation of Tacrolimus serum concentration fluctuation rate and transplanted kidney function in kidney transplant patients. （Speech，General） 2026/04/23
5.	Relative changes in donor-derived cell-free DNA as a marker of allograft rejection in a kidney transplant recipient with metastatic cancer undergoing immunotherapy. （Poster notice，General） 2025/08/05
6.	Incidence and causes of surgical reintervention following living kidney transplantation: Insights from 534 consecutive cases. （Poster notice，General） 2025/08/04
7.	Surgical complications and risk factors in 2,095 cases of pure retroperitoneoscopic living donor nephrectomy: A 20-year experience. （Poster notice，General） 2025/08/04
8.	The coefficient of variation of tacrolimus QD at 1 year posttransplant is associated with mid-long term kidney graft function. （Poster notice，General） 2025/08/04
9.	Long-term outcomes of cross-match positive living kidney transplantation: A retrospective study. （Poster notice，General） 2025/08/03
10.	Performance of donor-derived cell-Free DNA testing for rejection detection in Japanese kidney transplants: Insights from a multicenter study. （Poster notice，General） 2025/08/03
11.	A novel measurement for parenchymal stiffness of renal allograft in patients after kidney transplantation. （Speech，General） 2025/07/01
12.	Investigation of blood mycophenolic acid concentrations and influencing factors in patients after kidney transplantation. （Poster notice，General） 2025/06/29
13.	Predictive value of HLAMatchmaker and PIRCHE-II scores for de novo donor-specific antibody formation after kidney transplantation-A Japanese single-center study. （Poster notice，General） 2024/11/14
14.	Relationship between Parenchymal Stiffness and Renal Fibrosis in Kidney Transplant Recipients （Poster notice，General） 2024/10/24
15.	Long-term antibody response differences after SARS-CoV-2 vaccination in kidney transplant recipients and dialysis patients. （Poster notice，General） 2024/09/14
16.	Clinicopathological evaluation of living-related kidney transplantation from older adult donors: A focus on zero-time biopsy findings. （Poster notice，General） 2024/06/04
17.	Predicting short-term outcomes of living kidney donor by machine learning. （Poster notice，General） 2024/06/01
18.	The association between parenchymal stiffness and renal allograft fibrosis in kidney transplant recipients. （Poster notice，General） 2024/06/01
19.	The potential of donor-derived-cell-free DNA for rejection diagnosis in Japanese cohort. （Poster notice） 2024/04/25
20.	Elderly living kidney transplant donors and their renal prognosis. （Poster notice，General） 2023/06/06
21.	Safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitor in kidney transplant patients with post-transplant anemia. （Poster notice，General） 2023/06/05
22.	Effects and side effects of desensitization therapy in flow cytometry crossmatch-negative, Low-dose donor-specific antibody-positive renal transplant recipients. （Poster notice，General） 2023/06/04
23.	Impact of current desensitization protocols and surgical outcomes in ABO-incompatible kidney transplant recipients: A Japanese single-center experience. （Poster notice，General） 2023/06/04
24.	Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation. （Poster notice，General） 2023/06/03
25.	Outcomes of kidney transplantation recipients with Covid-19 infection : 282 Cases of a Single-Center experience. （Poster notice，General） 2023/06/03
26.	Sars-Cov-2 antibody kinetics after vaccination in solid organ transplant recipients: multicenter study. （Poster notice，General） 2023/06/03
27.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. （Poster notice，General） 2023/06/03
28.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. （Poster notice，General） 2023/06/03
29.	A case of renal transplantation with CAAMR revealed by a novel HLA antibody approach. （Poster notice，General） 2023/04/29
30.	Postoperative management of renal transplantation: what you need to know. （Speech，Panelist at Symposium/Workshop (Other)） 2023/04/21
31.	10-years long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation. （Speech，General） 2023/04/20
32.	A case of living kidney transplantation suspected of hyper-acute rejection during kidney transplant surgery. （Speech，General） 2022/11/26
33.	Antibody response after SARS-CoV-2 mRNA vaccines in previously infected kidney transplant recipients. （Speech，General） 2022/11/26
34.	Clinicopathological analyses of chronic vascular rejection after kidney transplantation. （Speech，General） 2022/11/26
35.	Cost effectiveness of kidney transplantation in high-immunological risk patients in a Japan cohort. （Speech，General） 2022/11/26
36.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. （Speech，General） 2022/11/26
37.	Outcomes of ABO-compatible living kidney transplantation recipients with low immunological risk. （Speech，General） 2022/11/26
38.	Outcomes of kidney transplantation recipients with SARS-CoV-2 infection: A single-center experience. （Speech，General） 2022/11/26
39.	SARS-CoV-2 antibody kinetics after second dose of vaccination in solid organ transplant recipients. （Speech，General） 2022/11/26
40.	A case of kidney transplantation after multiple urinary tract conversion with an ileal conduit. （Speech，General） 2022/11/25
41.	Evaluation of cases of cytomegalovirus infection after renal transplantation at our department. （Speech，General） 2022/11/25
42.	Preconception care and pregnancy complications after kidney transplantation: A single-center study. （Speech，General） 2022/11/25
43.	Recurrence of cancer in 188 kidney transplant recipients. （Speech，General） 2022/11/25
44.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. （Poster notice，General） 2022/10/24
45.	Desensitization protocol to prevent severe oliguric antibody-mediated rejection. （Poster notice，General） 2022/06/05
46.	SARS-CoV-2 antibodies transitions after vaccination in solid organ transplant recipients: Multicenter study in Japan. （Poster notice，General） 2022/06/05
47.	Two times or more double-filtration plasmapheresis increases the risk of bleeding during kidney transplantation. （Poster notice，General） 2022/06/05
48.	Relationship between tacrolimus blood levels and covid-19 pandemic in kidney transplant recipients. （Poster notice，General） 2021/06/04
49.	The evaluation of living-related kidney transplantation donors in autosomal-dominant polycystic kidney disease. （Poster notice，General） 2021/06/04
50.	Pathological investigation about renal transplant lost allografts. （Speech，General） 2020/12/23
51.	Quantitative analysis of humoral immunity by flow-cytometric crossmatch using molecules of equivalent soluble fluorochromosome (FCXM-MESF). （Poster notice，General） 2020/05/30
52.	Correlation between the HLA antibody screening test and the specificity identification test. （Poster notice，General） 2019/09/15
53.	Pregnancy outcomes in kidney transplant recipients. （Poster notice，General） 2019/06/03
54.	Return to work after sick leave in kidney transplant recipients: A 365day cohort of the Japan academic consortium of kidney transplantation (JACK) study. （Poster notice，General） 2019/06/03
55.	Clinical and pathological analysis of chronic vascular rejection after renal transplantation. （Speech，General） 2018/07/21
56.	Outcomes of retroperitoneoscopic live donor nephrectomy (RPLDN): Experience of 1100 cases at a single center. （Poster notice，General） 2018/06/04
57.	Recurrence of immunoglobulin a nephropathy in related donor kidney transplant recipients. （Speech，General） 2018/06/03
58.	Relation between seroprevalence of cytomegalovirus and graft survival in Japanese kidney transplant recipients: The Japan academic consortium of kidney transplantation study. （Poster notice，General） 2018/06/02
59.	Monoclonal IgG Deposits on Tubular Basement Membrane in Renal Allograft: Is This Significant for Chronic Allograft Injury? （Poster notice，General） 2017/11/04
60.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. （Poster notice，General） 2017/05/02
61.	Renal transplantation to the extraperitoneal cavity in children weighing less than 15 kg can be performed safely. （Poster notice，General） 2017/05/02
62.	A comparative study of patient and graft qualities between abo- compatible and- incompatible recipients more than ten years after kidney transplantation. （Poster notice，General） 2017/05/01
63.	Manipulate innate immune cells; breakthrough for acquiring transplant tolerance. （Speech，General） 2017/03/25
64.	Combination of veto cell transfer and NKT cell therapy helps establish complete hematopoietic chimerism in non-myeloablative BMT recipients. （Poster notice，General） 2016/12/06
65.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. （Speech） 2016/10/29
66.	Post-transplant diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study. （Speech，General） 2016/08/23
67.	Clinical and pathological analyses of interstitial fibrosis and tubular atrophy (IF/TA) cases after kidney transplantation. （Poster notice，General） 2016/08/20
68.	Comparison of the pharmacokinetics and pathology for low-dose once-daily and twice-daily tacrolimus following living kidney transplantation: Five-year results from a prospective trial. （Poster notice，General） 2016/08/20
69.	Postoperative rebound of anti-blood type antibodies and antibody-mediated rejection after ABO-incompatible living related kidney transplantation: Is prophylactic treatment necessary? （Poster notice，General） 2016/08/20
70.	Relationship between dialysis duration and prevalence of cardiovascular diseases in kidney transplantation recipients. （Poster notice，General） 2016/08/20
71.	Pharmakokinetics of prolonged-release formulation of tacrolimus:Comparison of AUC0-24 and concentration at 10 time points. （Poster notice，General） 2016/06/13
72.	Relationship between dialisys duration and prevalence of cardiovascular diseases in kidney transplantation recipients. （Poster notice，General） 2016/06/13
73.	The significance of microvascular inflammation in antibody-mediated rejection in ABO-incompatible kidney transplantation. （Poster notice，General） 2016/06/13
74.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. （Poster notice，General） 2016/06/11
75.	Association between pretransplant body mass index and outcomes in patients undergoing living kidney transplantation: A consideration of gender differences. （Poster notice，General） 2016/06/11
76.	Clinical outcome of elderly living kidney donors: A single-center study in Japan. （Poster notice，General） 2016/06/11
77.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation - Prospective trial of once-daily vs.twice-daily Tac - 5 years second report. （Poster notice，General） 2016/06/11
78.	Sequential analysis of donor-specific antibodies and pathological findings using intravenous immunoglobulin in a highly sensitized rat kidney transplant model. （Poster notice，General） 2016/06/11
79.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation （Poster notice，General） 2015/11/07
80.	Successful ABO-blood group incompatible kidney transplantation under eculizumab induction. （Poster notice，General） 2015/09/13
81.	Short-term outcomes of angioplasty in situ for renal artery aneurysm. （Speech，General） 2015/05/18
82.	Incidence of hepatitis B virus reactivation in kidney transplant patients who received rituximab administration. （Poster notice，General） 2015/05/05
83.	The clinical outcome of plasma cell-rich rejection of kidney allograft. （Poster notice，General） 2015/05/05
84.	Regulatory T cells expanded by activated iNKT cells facilitate migration of donor dendritic cells into the recipient thymus and subsequent establishment of clonal deletion. （Speech，General） 2015/05/04
85.	The effect of rituximab therapy on regulatory B cell and prevention of chronic antibody mediated rejection in kidney transplantation recipients. （Speech，General） 2015/05/04
86.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. （Poster notice，General） 2015/05/03
87.	Outcome of kidney transplantation from obese living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
88.	Outcome of kidney transplantation from older living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
89.	Outcome of kidney transplantation using right versus three left renal arteries after retroperitoneoscopic donor nephrectomy:A single-center experience of 764 cases. （Poster notice，General） 2015/05/03
90.	T cell transfer with iNKT cell activation facilitate engraftment of bone marrow cells without GvHD. （Poster notice，General） 2015/05/03
91.	An Investigation of 12 cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation （Poster notice，General） 2015/05/02
92.	Donor specific tolerance can be induced by donor bone marrow transfer with activation of invariant naturel killer T cells. （Poster notice，General） 2015/05/02
93.	Excellent outcomes of prophylactic rituximab administration with plasmapheresis in kidney transplant recipients with focal segmental glomerulosclerosis. （Poster notice，General） 2015/05/02
94.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. （Poster notice，General） 2015/05/02
95.	Impact of right nephrectomy on long-term outcomes in retroperitoneoscopic live donor nephrectomy. （Poster notice，General） 2014/09/04
96.	Efficacy of rituximab, an anti-CD20 antibody for preventing hemolysis due to passenger leucocyte syndrome (PLS). （Poster notice，General） 2014/07/30
97.	A novel approach inducing transplant tolerance by activated invariant natural killer T cells with co-stimulatory blockade. （Speech，General） 2014/07/29
98.	Analysis of predictive and preventive factors for de novo DSA in Non-HLA sensitized kidney transplant recipients. （Poster notice，General） 2014/07/29
99.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation -prospective trial of once-daily vs. twice-daily tac -3 years second report. （Poster notice，General） 2014/07/29
100.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. （Speech，General） 2014/07/29
101.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. （Poster notice，General） 2014/07/29
102.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. （Poster notice，General） 2014/07/29
103.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. （Poster notice，General） 2014/07/29
104.	Risk factors of preterm delivery at less than 35 weeks in patients with kidney transplantation. （Poster notice，General） 2014/07/29
105.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. （Speech，General） 2014/07/29
106.	Assessment of long-term outcomes after kidney retransplantation. （Poster notice，General） 2014/07/28
107.	Low incidence of new onset diabetes mellitus after renal transplantation under low-dose tacrolimus-based immunosuppression: A single center experience. （Poster notice，General） 2014/07/28
108.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. （Poster notice，General） 2014/07/28
109.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. （Poster notice，General） 2014/07/28
110.	Association between age and kidney transplantation outcome: Does age matter? （Poster notice，General） 2014/07/27
111.	Changes in ABO-blood type antibody titers after single-dose rituximab administration. （Poster notice，General） 2014/07/27
112.	Influences of the CD20 Ab rituximab on the renal transplant recipients and renal grafts 5 to 8 years after immunologically high-risk renal transplantation. （Poster notice，General） 2014/07/27
113.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. （Poster notice，General） 2014/07/27
114.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. （Poster notice，General） 2014/07/27
115.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution （Poster notice，General） 2013/09/04
116.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity （Speech，General） 2013/09/04
117.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment （Poster notice，General） 2013/05/21
118.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for over 20 Years （Speech，General） 2013/05/21
119.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression （Poster notice，General） 2013/05/21
120.	Evaluation of Low-Dose Rituximab Treatment;the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients （Poster notice，General） 2013/05/20
121.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity （Poster notice，General） 2013/05/19
122.	Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a BCell-Depleting Treatment （Poster notice，General） 2013/05/19
123.	Influence of Preoperative Anti-HLA Antibodies on Short-Term and Long-Term Graft Survival in Recipients With or Without Rituximab Treatment （Speech，General） 2013/05/19
124.	Microvascular Inflammation as a Core Element of Diagnostic Criteria of Antibody-Mediated Rejection(ABMR): C4d Positivity Is Not Reliable Element in Diagnosis of ABMR （Speech，General） 2013/05/19
125.	Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model （Poster notice，General） 2013/05/19
126.	The Significance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection （Speech，Panelist at Symposium/Workshop (Other)） 2013/02/09
127.	MFI Detected by Luminex in Patients with Chronic Active Antibody Mediated Rejection （Poster notice，General） 2012/10/20
128.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries （Speech，General） 2012/10/20
129.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases （Poster notice，General） 2012/07/19
130.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation （Poster notice，General） 2012/07/19
131.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for Over 20 Years （Speech，General） 2012/07/19
132.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome(FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation （Poster notice，General） 2012/07/19
133.	The Signifi cance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection （Speech，General） 2012/06/05
134.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases （Speech，General） 2012/06/04
135.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation （Speech，General） 2012/06/04
136.	The Impact of B-Cell Depleting Treatment on Marked Reduction of Chronic Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation （Speech，General） 2012/06/04
137.	An Open Label, Prospecive Randomized Controlled Study Comparing Tacrolimus Once-Daily and Twice-Daily in De Novo Kidney Transplatation: Pharmacokinetics and Pathological Analysis by Protocol Biopsy （Speech，General） 2012/06/03
138.	Long-Term Follow-Up of Kidney Transplant Recipient with Calcineurin Inhibitor-Associated Nephrotoxicity （Speech，General） 2012/06/03
139.	Neutrophil Gelatinase-Associated Lipocalin Is Most Sensitive to the Acute Rejection after Living Donated Kidney Transplantation （Speech，General） 2012/06/03
140.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years （Speech，General） 2012/06/02
141.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy （Speech，General） 2012/04/23
142.	Detectability of renal arteries in living renal donors using MDCT: comparison among axial images and three-dimensional reconstruction images （Poster notice，General） 2012/03
143.	Prophylactic therapy for antibody-mediated rejection during introductory period in kidney transplantation(Symposium7 Antibody-mediated rejection in kidney transplantation) （Speech，Panelist at Symposium/Workshop (Other)） 2012/02/03
144.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy （Speech，General） 2011/11/30
145.	Chimerism of blood type antigens on the vessel endothelium in patients with antibody-mediated rejection （Speech，General） 2011/09/04
146.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation （Speech，General） 2011/06
147.	Impact and Implication of Renal Artery Number on Outcomes of Renal Donors and Recipients in Retroperitoneoscopic Live Donor Nephrectomy-Experience of 500 Cases at a Single Center （Poster notice，General） 2011/05/03
148.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy:Experience of 479 Cases at a Single Center （Poster notice，General） 2011/05/03
149.	Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 500 Cases at a Single Center （Poster notice，General） 2011/05/03
150.	Excellent Outcomes of Rituximab Administration Plus Plasmapheresis as Prophylactic Treatment Prior to Kidney Transplantation in Patients with Focal Segmental Glomerulosclerosis （Poster notice，General） 2011/05/02
151.	Decrease of Blood-Type Antigenicity over the Long-Term after ABO-Incompatible Kidney Transplantation （Poster notice，General） 2011/05/01
152.	Significance of Qualitative and Quantitative Evaluations of Anti-HLA Antibodies in Kidney Transplantation （Poster notice，General） 2011/05/01
153.	Significant Reduction in Chronic Antibody-Mediated Rejection after B-Cell Depleting Treatment in ABO-Incompatible Living Kidney Transplantation （Speech，General） 2011/05/01
154.	Rituximab Therapy Reduces Peripheral B Cells for a Long Time in ABO Incompatible Kidney Transplantation; a Single Center Experience （Poster notice，General） 2011/04/30
155.	The Efficacy of Interleukin-6 Receptor Signaling Blockade during Acute and Chronic Rejection in a Cardiac Allograft Transplantation Murine Model （Poster notice，General） 2011/04/30
156.	MRI findings of the post-transplant lymphoproliferative disorder (PTLD) of the central nervous system (CNS) （Speech，General） 2010/05/10
157.	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors （Speech，General） 2010/05
158.	Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation （Speech，General） 2010/05
159.	Complications and excellent graft functions of retroperitoenoscopic living donor nephrectomy at single center experiment （Speech，General） 2010/05
160.	Excellent long-term outcomes of donor-specific anti-HLA antibody(DSA) positive renal transplant recipients and significant elimination of posttransplant DSA by combination treatment of basiliximab and rituxaimab inductoin （Speech，General） 2010/05
161.	Impact of right nephrectomy on outcomes of renal function and complications in retroperitoneoscopic live donor nephrectomy:experience of 425 cases at a single center （Speech，General） 2010/05
162.	Lymphopenia-induced proliferation of lymphocytes results in chronic rejection of mice cardiac allografts （Speech，General） 2010/05
163.	Lymphopenia-indued proliferation of lymphocytes results in chronic rejection of mice cardiac allografts （Speech，General） 2010/05
164.	Outcome of kidney transplantation from living older donors: histologiucal evaluation using zero-time biopsy （Speech，General） 2010/05
165.	Outcome of retroperitoneoscopic living donor nephrectomy in obese donors （Speech，General） 2010/05
166.	The effect of anti IL-6 receptor monoclonal antibody during acute and chronic rejection in a cardiac allograft transplantation murine model （Speech，General） 2010/05
Display 5 items
Display all(166)

■ Research areas

Urology, Immunology (Key Word：kidney transplantation, immunological tolerance, bone marrow transplantation)

■ Education

1992/04～1996/03

〔Doctoral course〕〔Doctorial Course〕 Speciality, Division of Surgery, Graduate School, Division of Medical Sciences, Kyushu University, Completed, Doctor of Medicine, Doctor of Philosophy